Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Daidone

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|June 19, 1991
Laminin receptors, collagenase IV and prognosis in node-negative breast cancersM G Daidone, R Silvestrini, A D'Errico, et al.
European Journal of Nuclear Medicine|November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationF Crippa, E Seregni, R Agresti, et al.
Cell Death & Disease|July 30, 2016
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblastsS Baroni, S Romero-Cordoba, I Plantamura, et al.
Leukemia|March 10, 2006
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical resultsD Coradini, C Pellizzaro, I Scarlata, et al.
The International Journal of Biological Markers|July 19, 2006
Questioning the utility of pooling samples in microarray experiments with cell linesL Lusa, V Cappelletti, M Gariboldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2013
Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancerR Orlandi, M De Bortoli, C M Ciniselli, et al.
Investigational New Drugs|February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialA Necchi, P Giannatempo, L Mariani, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Biomed Research International|August 2, 2018
PATRI, a Genomics Data Integration Tool for Biomarker DiscoveryG Ukmar, G E M Melloni, L Raddrizzani, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|June 19, 1991
Laminin receptors, collagenase IV and prognosis in node-negative breast cancersM G Daidone, R Silvestrini, A D'Errico, et al.
European Journal of Nuclear Medicine|November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationF Crippa, E Seregni, R Agresti, et al.
Cell Death & Disease|July 30, 2016
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblastsS Baroni, S Romero-Cordoba, I Plantamura, et al.
Leukemia|March 10, 2006
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical resultsD Coradini, C Pellizzaro, I Scarlata, et al.
The International Journal of Biological Markers|July 19, 2006
Questioning the utility of pooling samples in microarray experiments with cell linesL Lusa, V Cappelletti, M Gariboldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2013
Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancerR Orlandi, M De Bortoli, C M Ciniselli, et al.
Investigational New Drugs|February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialA Necchi, P Giannatempo, L Mariani, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Biomed Research International|August 2, 2018
PATRI, a Genomics Data Integration Tool for Biomarker DiscoveryG Ukmar, G E M Melloni, L Raddrizzani, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Pageof 11